Anistreplase drug data and news

Anistreplase drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Anistreplase
Brand Names/Synonyms Tissue-type plasminogen activator precursor;tPA;t- PA;t-plasminogen activator;Alteplase;Reteplase; Eminase (Wulfing Pharma GmbH)
Indication For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction
Sponsored links
Description Human tissue plasminogen activator, purified, glycosylated, 527 residues purified from CHO cells. Eminase is a lyophilized (freeze-dried) formulation of anistreplase, the p-anisoyl derivative of the primary Lys-plasminogen-streptokinase activator complex (a complex of Lys-plasminogen and streptokinase). A p-anisoyl group is chemically conjugated to a complex of bacterial-derived streptokinase and human Plasma-derived Lys-plasminogen proteins.
Pharmacology Anistreplase cleaves the Arg/Val bond in plasminogen to form plasmin. Plasmin in turn degrades the fibrin matrix of the thrombus, thereby exerting its thrombolytic action. This helps eliminate blood clots or arterial blockages that cause myocardial infarction.
Mechanism Of Action Anistreplase cleaves the Arg/Val bond in plasminogen to form plasmin. This in turn leads to the degradation of blood clots.
Anistreplase News
(When available)
[an error occurred while processing this directive]
Dosage Forms POWDER FOR SOLUTION
Drug_Category Thrombolytic Agents
Absorption Not Available
Interactions Not Available
Toxicity Not Available
Organisms Affected Humans and other mammals
Chemical IUPAC Name Human tissue plasminogen activator
Chemical Formula C2569H3928N746O781S40
Molecular Weight 59042.3
Smiles String Not Available
Melting Point 60 oC (Novokhatny, V.V. et al., J. Biol. Chem. 266:12994-123002 (1991))
Water Solubility Not Available
State Transparent, slightly viscous, aqueous liquid
LogP/Hphobicity -0.516
Isoelectric Point 7.61
Biotransformation Not Available
Half Life Not Available
Protein Binding [%] Not Available
RxList Link Not Available>RXlist
Sponsored links
Drug Reference http://www.drugs.com/cons/Anistreplase.html
Drug Type Approved Drug
Accession No BIOD00102
CAS Registry Number 81669-57-0
KEGG Compound ID Not Available
PubChem ID Not Available
PharmGKB ID PA448439
SwissProt ID TPA_HUMAN (P00750)
GenBank ID L00153
Drug ID Number [DIN] 2229390

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org